Paul Posadzki1, Leala Watson, Edzard Ernst. 1. Complementary Medicine, Peninsula Medical School, University of Exeter, Veysey Building, Salmon Pool Lane, Exeter EX2 4SG, England. paul.posadzki@pcmd.ac.uk
Abstract
OBJECTIVES: The aim of this overview of systematic reviews (SRs) is to evaluate critically the evidence regarding interactions between herbal medicinal products (HMPs) and synthetic drugs. METHODS: Four electronic databases were searched to identify relevant SRs. RESULTS: Forty-six SRs of 46 different HMPs met our inclusion criteria. The vast majority of SRs were of poor methodological quality. The majority of these HMPs were not associated with severe herb-drug interactions. Serious herb-drug interactions were noted for Hypericum perforatum and Viscum album. The most severe interactions resulted in transplant rejection, delayed emergence from anaesthesia, cardiovascular collapse, renal and liver toxicity, cardiotoxicity, bradycardia, hypovolaemic shock, inflammatory reactions with organ fibrosis and death. Moderately severe interactions were noted for Ginkgo biloba, Panax ginseng, Piper methysticum, Serenoa repens and Camellia sinensis. The most commonly interacting drugs were antiplatelet agents and anticoagulants. CONCLUSION: The majority of the HMPs evaluated in SRs were not associated with drug interactions with serious consequences. However, the poor quality and the scarcity of the primary data prevent firm conclusions.
OBJECTIVES: The aim of this overview of systematic reviews (SRs) is to evaluate critically the evidence regarding interactions between herbal medicinal products (HMPs) and synthetic drugs. METHODS: Four electronic databases were searched to identify relevant SRs. RESULTS: Forty-six SRs of 46 different HMPs met our inclusion criteria. The vast majority of SRs were of poor methodological quality. The majority of these HMPs were not associated with severe herb-drug interactions. Serious herb-drug interactions were noted for Hypericum perforatum and Viscum album. The most severe interactions resulted in transplant rejection, delayed emergence from anaesthesia, cardiovascular collapse, renal and liver toxicity, cardiotoxicity, bradycardia, hypovolaemic shock, inflammatory reactions with organ fibrosis and death. Moderately severe interactions were noted for Ginkgo biloba, Panax ginseng, Piper methysticum, Serenoa repens and Camellia sinensis. The most commonly interacting drugs were antiplatelet agents and anticoagulants. CONCLUSION: The majority of the HMPs evaluated in SRs were not associated with drug interactions with serious consequences. However, the poor quality and the scarcity of the primary data prevent firm conclusions.
Authors: Catherine Ulbricht; Ethan Basch; Mamta Vora; David Sollars; Adrianne Rogers; Samuel Basch; Michael Smith; Howard Moffet; Paul Hammerness Journal: J Herb Pharmacother Date: 2003
Authors: Catherine Ulbricht; Julie Conquer; Dawn Costa; Whitney Hollands; Carmen Iannuzzi; Richard Isaac; Joseph K Jordan; Natalie Ledesma; Cathy Ostroff; Jill M Grimes Serrano; Michael D Shaffer; Minney Varghese Journal: J Diet Suppl Date: 2011-03
Authors: Catherine Ulbricht; Julie Conquer; Dawn Costa; William Hamilton; Elizabeth R B Higdon; Richard Isaac; Erica Rusie; Idalia Rychlik; Jill M Grimes Serrano; Shaina Tanguay-Colucci; Mark Theeman; Minney Varghese Journal: J Diet Suppl Date: 2011-06
Authors: Richard D Boyce; Isabelle Ragueneau-Majlessi; Jingjing Yu; Jessica Tay-Sontheimer; Chris Kinsella; Eric Chou; Mathias Brochhausen; John Judkins; Brandon T Gufford; Bruce E Pinkleton; Rebecca Cooney; Mary F Paine; Jeannine S McCune Journal: AMIA Annu Symp Proc Date: 2018-12-05
Authors: Joshua J Kellogg; Mary F Paine; Jeannine S McCune; Nicholas H Oberlies; Nadja B Cech Journal: Nat Prod Rep Date: 2019-08-14 Impact factor: 13.423